Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen A Grace

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Patient Preference and Adherence|November 26, 2009
Ten lessons learned from conducting an adherence intervention trialJeannie K Lee, Karen A Grace, Allen J Taylor
JAMA|November 15, 2006
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trialJeannie K Lee, Karen A Grace, Allen J Taylor
Circulation|November 13, 2004
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statinsAllen J Taylor, Lance E Sullenberger, Hyun J Lee, et al.
Canadian Family Physician Medecin De Famille Canadien|February 18, 2022
Tool to improve patient-provider interactions in adult primary care: Randomized controlled pilot studyPatrick G O'Malley, Jeffrey L Jackson, Dorothy Becher, et al.
Vascular Health and Risk Management|June 23, 2007
Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2Allen J Taylor, Daming Zhu, Lance E Sullenberger, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 18, 2002
Implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitorsKaren A Grace, Jennifer Swiecki, Richard Hyatt, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
How should we measure medication adherence in clinical trials and practice?Jeannie K Lee, Karen A Grace, Terri G Foster, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Patient Preference and Adherence|November 26, 2009
Ten lessons learned from conducting an adherence intervention trialJeannie K Lee, Karen A Grace, Allen J Taylor
JAMA|November 15, 2006
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trialJeannie K Lee, Karen A Grace, Allen J Taylor
Circulation|November 13, 2004
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statinsAllen J Taylor, Lance E Sullenberger, Hyun J Lee, et al.
Canadian Family Physician Medecin De Famille Canadien|February 18, 2022
Tool to improve patient-provider interactions in adult primary care: Randomized controlled pilot studyPatrick G O'Malley, Jeffrey L Jackson, Dorothy Becher, et al.
Vascular Health and Risk Management|June 23, 2007
Relationship between glycemic status and progression of carotid intima-media thickness during treatment with combined statin and extended-release niacin in ARBITER 2Allen J Taylor, Daming Zhu, Lance E Sullenberger, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 18, 2002
Implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitorsKaren A Grace, Jennifer Swiecki, Richard Hyatt, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
How should we measure medication adherence in clinical trials and practice?Jeannie K Lee, Karen A Grace, Terri G Foster, et al.
Pageof 1